About this trial
The purpose of this study is to elucidate the mechanisms underlying eosinophil growth, survival, migration, and function and to investigate and further characterize the pathophysiology of, clinical manifestations of, and spectrum of disease severity of eosinophilic inflammation in humans.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Signed informed consent obtained from the patient or parent/guardian. Assent will be obtained from all minors 11 years of age and older.
Carrying a diagnosis of eosinophilic gastrointestinal disease, eosinophilic inflammatory disease, or food allergy OR family member, or normal control
Disqualifiers
None
Trial population
Patients with eosinophilic disorders and patients without eosinophilic disorders to serve as normal controls
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
This trial has no outcomes listed.Sponsors and contacts
Click on the lead sponsor to view all of their trials.